Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 518Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Cohance Lifesciences

02 1ANI Pharmaceuticals Inc

03 2Actavis Inc

04 3Avet Pharmaceuticals

05 2Dastech International Inc

06 2Merck & Co

07 2PUREPAC PHARM

08 2Teva Pharmaceutical Industries

09 1Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Diflunisal

Brand Name :

Dosage Form : Tablet

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

02

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1997-07-17

Application Number : 74400

Regulatory Info : DISCN

Registration Country : USA

blank

03

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 1997-07-17

Application Number : 74400

Regulatory Info : DISCN

Registration Country : USA

blank

04

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 1996-06-10

Application Number : 74604

Regulatory Info : DISCN

Registration Country : USA

blank

05

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2012-03-08

Application Number : 202845

Regulatory Info : RX

Registration Country : USA

blank

06

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 2024-08-16

Application Number : 202845

Regulatory Info : RX

Registration Country : USA

blank

07

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 375MG

Packaging :

Approval Date : 2024-08-16

Application Number : 202845

Regulatory Info : RX

Registration Country : USA

blank

08

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1992-11-27

Application Number : 73562

Regulatory Info : DISCN

Registration Country : USA

blank

09

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 1992-11-27

Application Number : 73563

Regulatory Info : DISCN

Registration Country : USA

blank

10

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DOLOBID

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-04-19

Application Number : 18445

Regulatory Info : DISCN

Registration Country : USA

blank

11

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DOLOBID

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-04-19

Application Number : 18445

Regulatory Info : DISCN

Registration Country : USA

blank

12

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1996-05-07

Application Number : 74285

Regulatory Info : DISCN

Registration Country : USA

blank

13

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 1996-05-07

Application Number : 74285

Regulatory Info : DISCN

Registration Country : USA

blank

14

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 1992-07-31

Application Number : 73673

Regulatory Info : RX

Registration Country : USA

blank

15

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1992-07-31

Application Number : 73679

Regulatory Info : DISCN

Registration Country : USA

blank

16

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

DIFLUNISAL

Brand Name : DIFLUNISAL

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2017-06-16

Application Number : 203547

Regulatory Info : RX

Registration Country : USA

blank